As Co-Chair of the University of Michigan Rogel Cancer Center Neuro-Oncology Clinical Research Team and Principal Investigator of multiple clinical trials, Dr. Kim is a leader in brain tumor clinical research and involved with efforts institutionally, regionally and nationally. Her primary focus is on the use of advanced imaging modalities as a biomarker to understand the biologic basis of tumor response and treatment resistance to radiation therapy, in order to individually adapt radiation treatment and improve outcome in patients with malignant gliomas. She is also interested in the evaluation of advanced imaging techniques to predict long-term toxicity and response in patients with low grade gliomas and brain metastases.
Disclosures:
- Employment: University of Michigan:Professor:Employee
- Compensation: Stanford U54 MetNet Advisory Board: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: Present ;ASTRO Annual Meeting Education Committee:Role Topic Description-End Date: Present ;Capital Health: Travel Expenses-End Date: 2022 ;Nebraska Oncology Society: Honoraria-End Date: 2022 ;PeerView: Honoraria, Travel Expenses-End Date: 11/16/23 ;Blue Earth Diagnostics: Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Honoraria-End Date: 12/01/2025 ;N
- Ownership: none
- Leadership: NCCN CNS Guidelines Committee Member:Member;Neuro-Oncology Editorial Board Member:Board Member;Red Journal:CNS Section Editor